NVIV

 
Common Stock
OTCQB
Contact Info
  • One Broadway
  • 14th Floor
  • Cambridge, MA 02142


Update Company Info
Business Description

InVivo Therapeutics Corporation is developing and intends to commercialize groundbreaking technologies for the treatment of spinal cord injuries (SCI). InVivo intends to leverage itsplatform technology to deliver three products to the market.

 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Not Available
Regulatory Agency Not Available
CIK 0001292519
Fiscal Year End 12/31
OTC Market Tier OTCQB
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: NV, USA
Year of Inc. Not Available
Employees Not Available
Company Officers
Frank M. Reynolds CEO, CFO
Company Directors
Not Available
Company Notes
  • Formerly=Design Source, Inc. until 10-2010
Service Providers
Auditor/Accountant
Wolf & Company, P.C.
Boston, MA, 02110
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available
NVIV Security Details
Share Structure
Market Value1 $141,361,401 a/o May 23, 2012
Shares Outstanding 63,964,435 a/o May 08, 2012
Float Not Available
Authorized Shares Not Available
Par Value 0.00001
Shareholders
Shareholders of Record 219 a/o Mar 15, 2012
Short Selling Data
Short Interest 178,203 (13.09%)
May 15, 2012
Significant Failures to Deliver No
Transfer Agent(s)
Continental Stock Transfer & Trust Company

1Market Value calculated only for respective security